SciELO - Scientific Electronic Library Online

 
vol.20 número1Ivabradine use in patients with HFrEF in the heart failure multidisciplinary program (PIC) in a private hospital: first registration and 3-years follow up, Central American (CA) region índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • No hay articulos similaresSimilares en SciELO

Compartir


Revista Costarricense de Cardiología

versión impresa ISSN 1409-4142

Resumen

HINOJAR, Rocío; JIMENEZ-NATCHER, José Julio; FERNANDEZ-GOLFIN, Covadonga  y  ZAMORANO, José Luis. Segunda Publicación Nuevos anticoagulantes orales: Guía práctica para los médicos. Rev. costarric. cardiol [online]. 2018, vol.20, n.1, pp.7-21. ISSN 1409-4142.

New oral anticoagulants suppose an attractive alternative for classical vitamin K antagonists (AVKs) in stroke prevention for patients with non-valvular atrial fibrillation. Unlike AVKs, these anticoagulants do not require monitoring or dose adjustment and have favourable pharmacological properties. The lack of an effective antidote, its cost, or doubts regarding the safety of patients with advanced kidney disease may explain its slow rate of expansion. The safe and effective use of these new medications depends largely on clinical experience among the medical community. This review discusses the peculiarities of the new oral anticoagulants, providing practical and easy-to-use algorithms for their application in daily clinical practice.

Palabras clave : atrial fibrillation; new oral anticoagulants; stroke.

        · resumen en Español     · texto en Español     · Español ( pdf )